← Back to guidelines
Cardiology101 papers

Neuronal intranuclear inclusion disease

Last edited: 4/22/2026

Overview

Neuronal intranuclear inclusion disease (NIID) is a rare, progressive, and typically fatal degenerative disorder characterized by eosinophilic intranuclear inclusions in neurons of the central and peripheral nervous systems. It can also involve extraneural tissues such as myocardium, as evidenced by cases with cardiomyopathy 2.

Diagnosis

  • Presence of eosinophilic intranuclear inclusions in neurons of the central and peripheral nervous systems.
  • Clinical manifestations include neurological symptoms like muscle spasms, dysarthria, dysphagia, tremors, ataxia, and progressive muscle weakness 3.
  • Histopathological examination of brain, brainstem, cerebellum, spinal cord, and other affected organs (e.g., bowel, bladder, esophagus) is crucial for diagnosis 3.
  • Unique presentations may include cardiomyopathy with intranuclear inclusions in cardiac myocytes 2.
  • Management

  • No specific curative treatments are mentioned; management is largely supportive.
  • Hyperbaric oxygenation shows potential neuroprotective effects in ischemic models, though its direct application in NIID is not discussed 1.
  • Focus on symptomatic treatment and supportive care for neurological and systemic symptoms 3.
  • Special Populations

  • Pediatrics: Early onset (as young as 3 years) with rapid progression has been observed 23.
  • Comorbidities: Association with severe coronary atherosclerosis in young adults suggests cardiovascular monitoring is essential 3.
  • Key Recommendations

  • Conduct comprehensive histopathological examination of affected tissues, including brain, spinal cord, and extraneural organs like myocardium, for definitive diagnosis (Evidence: Expert opinion 23).
  • Implement supportive care strategies tailored to manage neurological symptoms and systemic complications, given the lack of specific curative treatments (Evidence: Expert opinion 3).
  • Monitor for and manage potential cardiovascular involvement, especially in younger patients, due to reported associations with premature coronary atherosclerosis (Evidence: Expert opinion 3).
  • References

    1 Konda A, Baba S, Iwaki T, Harai H, Koga H, Kimura T et al.. Hyperbaric oxygenation prevents delayed neuronal death following transient ischaemia in the gerbil hippocampus. Neuropathology and applied neurobiology 1996. link 2 Oyer CE, Cortez S, O'Shea P, Popovic M. Cardiomyopathy and myocyte intranuclear inclusions in neuronal intranuclear inclusion disease: a case report. Human pathology 1991. link90296-2) 3 Parker JC, Dyer ML, Paulsen WA. Neuronal intranuclear hyaline inclusion disease associated with premature coronary atherosclerosis. Journal of clinical neuro-ophthalmology 1987. link

    Original source

    1. [1]
      Hyperbaric oxygenation prevents delayed neuronal death following transient ischaemia in the gerbil hippocampus.Konda A, Baba S, Iwaki T, Harai H, Koga H, Kimura T et al. Neuropathology and applied neurobiology (1996)
    2. [2]
    3. [3]
      Neuronal intranuclear hyaline inclusion disease associated with premature coronary atherosclerosis.Parker JC, Dyer ML, Paulsen WA Journal of clinical neuro-ophthalmology (1987)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG